Page last updated: 2024-11-04

sevoflurane and Squamous Cell Carcinoma of Head and Neck

sevoflurane has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"However, the effect of sevoflurane on head and neck squamous cell carcinoma (HNSCC) remains unclear."1.48Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro. ( Chen, Z; Hu, R; Jiang, H; Jiang, J; Lu, Y; Yan, J; Yang, Y, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, Y1
Hu, R1
Yan, J1
Chen, Z1
Lu, Y1
Jiang, J1
Jiang, H1

Other Studies

1 other study available for sevoflurane and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro.
    International journal of molecular medicine, 2018, Volume: 41, Issue:2

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Gene Expres

2018